Active Pharmaceutical Ingredients Market is Estimated to Perceive Exponential

1. Market Research Report EXCLUSIVE EDITION Active Pharmaceutical Ingredients Market Research Report Global Industry Analysis, Forecast and Trends, 2022-2030 © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

2. Global Active Pharmaceutical Ingredients Market © 2020 Statsville Consulting Private Limited Market Statsville Group (MSG) A part of Statsville Consulting Private Limited American Office American Office – 416, East Standsberry Street, Perkins, Oklahoma 74059, USA EMEA EMEA– 1165 Budapest 16 Diósy Lajos u. 24., Europe Asia Asia- -Pacific Office Pacific Office – F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 www.marketstatsville.com Disclaimer Disclaimer: : Any information and/or material provided by Statsville Consulting Private Limited, including any and all the analysis and/or research from Market Statsville Group (MSG), is offered to a selected group of customers in response to orders for such information, material, analysis, and/or research. As a customer of Statsville Consulting, you acknowledge that our information, material, and/or services are for your internal use only, and not for any external use and/or dissemination, or general publication, and/or disclosure to any third parties. Any and all the information and/or material provided by Statsville Consulting are based on primary interviews and/or secondary research, and are, therefore, subject to fluctuation and variance. Statsville Consulting takes no responsibility for any incorrect information and/or material supplied to us by sources we rely on, and no part of our analysis or research may be given, lent, resold, or disclosed to any third parties, including non-customers, without explicit or written permission from Statsville Consulting. Unauthorized reproduction and/or transmission of our information, material, analysis, and/or research in any form and by any means, including photocopying, mechanical/electronic recording,or otherwise, without the explicit and written permission of Statsville Consulting, is expressly and clearly prohibited. Any use of the information, material, analysis, and/or research provided by Statsville Consulting is at your sole risk; you acknowledge that the information, material, analysis, and/or research is provided “as is” and that Statsville Consulting provides no warranty of any kind, express or implied, with regard to the information, material, analysis, and/or research, including but not limited to, merchantability and fitness for any purpose and/or use. At the end, Statsville Consulting will be responsiblefor the final decision of any action. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

3. ABOUT MARKET STATSVILLE GROUP (MSG) Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG was initiated its working in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services. Market Statsville is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in the form of market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing a variety of customizable data that help you make decisions with clarity, confidence, and impact. Market Statsville is your global data intelligence partner for reliable market research data, data gathering, and analytical services. MSG also has an extensive network of top-flight domestic and global research personals around the world, enabling us to provide high-quality worldwide research solutions that cater to a well-established company, government organizations, or a startup. MSG's clients have the authority to work directly with one or more of our researchers to gather the most useful data knowledge and analytical plan to formulate it in the actual practice. Market Statsville Group believes that to succeed, companies or individuals must blend digital and human capabilities most efficiently. MSG diverse and experienced global team of business consultants and market researchers will ensure the valuable reports for our clients through digging in-depth market information and functional expertise to continuously spark the changes and real-time valuation of variation in the market/industry. MSG works in a uniquely collaborative model throughout the business process across the globe to assist the client's company with the most accurate information that they are aiming for in the reports. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

4. RESEARCH PROCESS Our research is an optimum culmination of secondary and primary research, with the latter playing a major role. We also have an in-house repository and access to a number of external regional and global paid databases to help address specific requirements of our clients. The research process begins with a holistic secondary research, followed by expert interviews. The information gathered is then comprehensively analyzed by our highly experienced in-house research panel © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

5. Active Pharmaceutical Ingredients Market 2022: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2030 Active Pharmaceutical Ingredients Market by Business Mode (Captive API and Merchant API), by Synthesis Type (Synthetic and Biotech), by Type (Generic and Branded), by Application (Cardiology, Pulmonology), by Region – Global Share and Forecast to 2030 Description Description The global active pharmaceutical ingredient market size was USD 177.0 billion in 2021, and it is estimated to reach USD 322.7 billion by 2030, registering a CAGR of 7.8% from 2022 to 2030. The rising research and development activities for drug manufacturing, the increasing importance of generics, and the increasing uptake of biopharmaceuticals are all driving the global active pharmaceutical ingredients market forward. However, growth is expected to be hampered by unfavorable drug price control policies and high manufacturing costs in various countries. The rising prevalence of chronic diseases is expected to increase drug demand, which will drive future growth in the active pharmaceutical ingredients market. In addition, new drug and biological product launches, acquisitions, collaborations, and regional expansions are some of the strategic initiatives to keep the market stable. This is likely to fuel future market growth. For instance, in 2020, Quartic.ai and Bright Path Labs collaborated to develop AI-based technology for the continuous manufacturing of critical APIs required for producing crucial small-molecule drugs. Get Full PDF Sample Copy of Report: https://www.marketstatsville.com/request-sample/active-pharmaceutical-ingredients- market © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

6. Global Active Pharmaceutical Ingredients Market (API) Definition Active pharmaceutical ingredients is substance or combination of substances used in a finished pharmaceutical product, intended to provide pharmacological activity or to otherwise have direct effect in the mitigation, diagnosis, treatment, cure, or prevention of disease, or to have direct effect in restoring, correcting or modifying physiological functions in human beings. Global Active Pharmaceutical Ingredients Market Covid-19 Impact The contagious coronavirus had potential economic impacts and implications on most sectors, including the pharmaceutical industry. Globally, governments are responding to the threat of COVID-19 with all the essential measures, such as travel restrictions, social distancing, nationwide lockdown, and large-scale quarantines, which are anticipated to negatively impact businesses and consumers spending. COVID-19 disrupts the pharmaceutical industry, causing drug shortages worldwide and exposing the need for a more resilient global supply chain. Thus, in India, strict regulations were imposed to tackle possible domestic shortages of medicines as the COVID-19 infection cases continued to rise in India. Due to the rising number of COVID-19 cases in India, the Indian Ministry of Commerce and Industry prohibited the export of 26 APIs and formulations using such APIs in March 2020. Global Active Pharmaceutical Ingredients Market Research Report Dynamics Drivers: Increasing Prevalence of Infectious, Genetic, Cardiovascular, and Other Chronic Disorders © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

7. Chronic diseases are the most prevalent health condition that involves significant expenditure globally. Chronic diseases include cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, and obesity, long-term disability, leading to hospitalization, reduced quality of life, and even death. According to the OECD, Health at a Glance, 2019 report, almost one-third of persons aged 15 years and over reported living with two or more chronic conditions, including cancer, heart attack and stroke, chronic respiratory problems, and diabetes, on average across 27 OECD countries globally. In Germany and Finland, the prevalence of chronic diseases rises to almost one in two. ?The growing cardiovascular disease cases are expected to further increase the demand for drugs, accelerating API production. Restraints: Drug Price-Control Policies across Various Countries A very little balance exists in protecting industry innovations while providing adequate accessibility and affordability for effective treatments. Many governments from various countries have taken initiatives to provide adequate access to treatments for diseases among the people. However, this has somehow restricted or limited the profit margins of the pharmaceutical companies. The drug price is controlled by the Pharmaceutical Benefits Scheme (PBS) in Australia. The PBS is a universally accessible national formulary that covers approximately 90% of prescriptions available in Australia. The Australian population has universal pharmaceutical insurance through PBS, which means that they are accessible to drugs at comparatively lower prices. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

8. The price of Australia’s drugs is lower than almost all the other OECD countries. Manufacturers have to list the drugs on PBS, which signifies that it is made cost-effective. This limits the profit margin of pharmaceutical companies. Make an Enquire before Purchase @: https://www.marketstatsville.com/buy-now/active-pharmaceutical-ingredients- market?opt=2950 Scope of the Global Active Pharmaceutical Ingredients Market The study categorizes the active pharmaceutical ingredients market based on business mode, synthesis type, application, and type at the regional and global levels. By Business Mode Outlook (Sales, USD Billion, 2017–2030) Captive API Merchant API By Synthesis Type Outlook (Sales, USD Billion, 2017–2030) Synthetic Biotech By Type Outlook (Sales, USD Billion, 2017–2030) Generic Branded © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

9. By Application Outlook (Sales, USD Billion, 2017–2030) Cardiology Pulmonology Oncology Ophthalmology Neurology Orthopedic Other Applications By Region Outlook (Sales, USD Billion, 2017–2030) North America (US, Canada, Mexico) South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America) Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe) Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific) The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA) The Captive API segment is accounted for the largest market share Based on business mode, the market is segmented into Captive API and Merchant API. The captive API segment is accounted for the largest market in 2021, with a market share of 64.8%. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

10. The captive API is defined as APIs used by pharmaceutical companies for the in-house production of finished dosage forms. Production of APIs has traditionally been done by pharmaceutical companies themselves in their home countries. However, many corporations have opted to send manufacturing overseas to cut costs in recent years. Request for Complete TOC and Figures & Graphs @ https://www.marketstatsville.com/table-of-content/active- pharmaceutical-ingredients-market Also, due to the current COVID-19 situation, companies, such as Amneal Pharmaceuticals, which performs captive APIs for its finished pharmaceutical products, have been facing hydroxychloroquine active pharmaceutical ingredients shortage after Finland tightens production, as drug makers have promised millions of doses for clinical trials and hospitals. Still, these shortages may impact market growth. Asia Pacific accounts for the highest CAGR during the forecast period The market has been studied based on global regions, including North America, Asia–Pacific, Europe, South America, and the Middle East & Africa. In the active pharmaceutical ingredients market, Asia Pacific is the fastest-growing region with a CAGR of 8.1% during the forecast period. China holds the largest market share in the Asia Pacific, whereas India is the fastest-growing country. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

11. Advancements in active pharmaceutical ingredient (API) manufacturing, growth of the biopharmaceutical sector, and increasing geriatric population are the key drivers of the regional market. In addition, the government of India is taking initiatives to boost biopharmaceutical products in the market, which will be beneficial for the market growth in the region. For instance, the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC) is taking various initiatives to promote research and development activities in biotechnology-based drugs. Request For Report Description @ https://www.marketstatsville.com/active-pharmaceutical-ingredients-market Key Market Players The active pharmaceutical ingredients market is mildly concentrated in nature with few numbers of global players operating in the market such as Aurobindo Pharma, Pfizer Inc., Novartis AG, BASF SE, Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd, Teva Pharmaceutical Industries Ltd, Lupin Ltd., Viatris, and Sun Pharmaceutical Industries Ltd. Every company follows its own business strategy to attain the maximum market share. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

12. Thank You Thank You Market Market Statsville Statsville Group (MSG) Group (MSG) F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 Phone : +91 702 496 8807 Mail : sales@marketstatsville.com 416, East Standsberry Street, Perkins, Oklahoma 74059, US Phone : +1 580 250 2707 Mail : sales@marketstatsville.com